From mRNA Science to Virus Vectors - Prime Time for Vaccine Technology

Explore the cutting-edge advancements in vaccine technology with a panel of experts in this hour-long conference talk from Aspen Ideas Health. Delve into the revolutionary mRNA science and virus vector technologies that have accelerated vaccine development, particularly in response to COVID-19. Learn about the potential applications beyond SARS-CoV-2, including targeted mRNA cancer vaccines and a universal influenza vaccine. Discover the challenges and promises of new vaccine technologies, their impact on disease prevention and treatment, and the future of vaccinology. Gain insights into vaccine production processes, immune responses, efficacy, safety regulations, and the development of second-generation vaccines. Engage with viewer questions and discussions on therapeutic antibodies, vaccine adaptability, and the highly regulated systems ensuring vaccine safety.

Introduction
How do they produce this vaccine
Cancer vaccines
mRNA vaccines
Inactivated vaccines
Challenges
Vaccine Technology
Immune Response
The Future
Vaccine Adaptability
Vaccination
Antibodies
Vaccines
Efficacy
Technology
Flu vaccines
Influenza vaccine
Supply of raw materials
Vaccine safety
Highly regulated systems
Viewers questions
Therapeutic antibodies
Second generation vaccines
Conclusion